| Metric | FY 2019 | Prior Q | FY 2018 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $52M | — | $48M | — | 7.8% |
| Op. Income | $14M | — | $14M | — | -0.7% |
| Gross Margin | 88.6% | — | 91.0% | — | -2.4pp |
| Net Margin | 21.2% | — | 23.4% | — | -2.2pp |
| EPS (Diluted) | $1.45 | — | $1.45 | — | 0.0% |
| Free Cash Flow | $2M | — | $19M | — | -89.0% |
| Item | Amount |
|---|---|
| REVENUE | $52M |
| Cost of Revenue | $6M |
| GROSS PROFIT | $46M |
| R&D Expenses | $0 |
| Selling & Marketing | $1M |
| General & Administrative | $22M |
| SG&A Expenses | $23M |
| Other Expenses | $9M |
| Operating Expenses | $32M |
| Cost & Expenses | $38M |
| OPERATING INCOME | $14M |
| Interest Income | $43M |
| Interest Expense | $6M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $14M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $11M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $11M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $11M |
| D&A | $2M |
| EBIT | $14M |
| EBITDA | $16M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $52M |
| Cost of Revenue | $6M |
| GROSS PROFIT | $46M |
| R&D Expenses | $0 |
| Selling & Marketing | $1M |
| General & Administrative | $22M |
| SG&A Expenses | $23M |
| Other Expenses | $9M |
| Operating Expenses | $32M |
| Cost & Expenses | $38M |
| OPERATING INCOME | $14M |
| Interest Income | $43M |
| Interest Expense | $6M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $14M |
| Income Tax Expense | $3M |
| Net Income from Continuing Ops | $11M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $11M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $11M |
| D&A | $2M |
| EBIT | $14M |
| EBITDA | $16M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $11M |
| Depreciation & Amortization | $2M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$6M |
| Change in Working Capital | -$2M |
| OPERATING CASH FLOW | $5M |
| Capital Expenditure | -$3M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$113M |
| Sales/Maturities of Investments | $85M |
| Other Investing Activities | -$18M |
| NET CASH FROM INVESTING | -$49M |
| Net Debt Issuance | -$20.0K |
| Common Stock Repurchased | -$6M |
| Common Dividends Paid | -$3M |
| Other Financing Activities | $68M |
| NET CASH FROM FINANCING | $60M |
| FREE CASH FLOW | $2M |
| Net Change in Cash | $15M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $48M |
| Short-Term Investments | $287M |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $334M |
| PP&E (Net) | $38M |
| Goodwill | $15M |
| Intangible Assets | $1M |
| Long-Term Investments | $744M |
| Tax Assets | $0 |
| Other Non-Current Assets | $37M |
| TOTAL NON-CURRENT ASSETS | $836M |
| TOTAL ASSETS | $1.2B |
| Account Payables | $0 |
| Short-Term Debt | $33M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $988M |
| TOTAL CURRENT LIABILITIES | $1.0B |
| Long-Term Debt | $15M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $10M |
| TOTAL NON-CURRENT LIABILITIES | $29M |
| TOTAL LIABILITIES | $1.1B |
| Common Stock | $7M |
| Additional Paid-In Capital | $90M |
| Retained Earnings | $20M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $2M |
| Other Equity | -$151.0K |
| TOTAL STOCKHOLDERS' EQUITY | $120M |
| Minority Interest | $0 |
| TOTAL EQUITY | $120M |
| TOTAL LIABILITIES & EQUITY | $1.2B |
| Total Debt | $52M |
| Net Debt | $4M |